Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

If conducted every year or every other year, the multi-cancer early detection blood test could help more people survive cancer, researchers reported Thursday in BMJ Open. Adobe stock/HealthDay May 9 ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

A programme to evaluate a blood test for early signs of pancreatic cancer has started to recruit volunteers. The Safe-D study, based in Southampton, Hampshire, is signing up patients with type 2 ...

Abu Dhabi has launched a revolutionary Multi-Cancer Early Detection (MCED) blood test, capable of identifying over 50 cancer ...

A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...

May 9 (UPI) --Blood tests could catch as many as half of cancers at an earlier, more treatable stage, a new study says. If conducted every year or every other year, the multi-cancer early detection ...